PT2118128E - Proteínas de fusão compreendendo os antigénios de rejeição tumoral ny-eso-1 e lage-1 - Google Patents

Proteínas de fusão compreendendo os antigénios de rejeição tumoral ny-eso-1 e lage-1 Download PDF

Info

Publication number
PT2118128E
PT2118128E PT87275889T PT08727588T PT2118128E PT 2118128 E PT2118128 E PT 2118128E PT 87275889 T PT87275889 T PT 87275889T PT 08727588 T PT08727588 T PT 08727588T PT 2118128 E PT2118128 E PT 2118128E
Authority
PT
Portugal
Prior art keywords
lage
eso
fusion proteins
tumor rejection
rejection antigens
Prior art date
Application number
PT87275889T
Other languages
English (en)
Inventor
Normand Blais
Denis Martin
Remi M Palmantier
Martine Boyer
Vincent Brichard
Jamila Louahed
Clement Rioux
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0700759A external-priority patent/GB0700759D0/en
Priority claimed from GB0701262A external-priority patent/GB0701262D0/en
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of PT2118128E publication Critical patent/PT2118128E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001184—Cancer testis antigens, e.g. SSX, BAGE, GAGE or SAGE
    • A61K39/001188—NY-ESO
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT87275889T 2007-01-15 2008-01-11 Proteínas de fusão compreendendo os antigénios de rejeição tumoral ny-eso-1 e lage-1 PT2118128E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0700759A GB0700759D0 (en) 2007-01-15 2007-01-15 Novel fusion protein
GB0701262A GB0701262D0 (en) 2007-01-23 2007-01-23 Vaccine
US91492507P 2007-04-30 2007-04-30
US91484807P 2007-04-30 2007-04-30

Publications (1)

Publication Number Publication Date
PT2118128E true PT2118128E (pt) 2013-01-29

Family

ID=39636996

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87275889T PT2118128E (pt) 2007-01-15 2008-01-11 Proteínas de fusão compreendendo os antigénios de rejeição tumoral ny-eso-1 e lage-1

Country Status (4)

Country Link
AR (1) AR064863A1 (pt)
AU (1) AU2008206463B2 (pt)
CL (1) CL2008000103A1 (pt)
PT (1) PT2118128E (pt)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ522066A (en) * 2000-03-30 2004-08-27 Dendreon Corp Compositions and methods for dendritic cell-based immunotherapy
AU2004314347B2 (en) * 2003-12-24 2011-05-19 Aduro Biotech, Inc. Recombinant nucleic acid molecules encoding fusion proteins comprising antigens and bacterial secretory signal polypeptides, expression cassettes, and bacteria, and methods of use thereof

Also Published As

Publication number Publication date
AU2008206463A1 (en) 2008-07-24
AU2008206463B2 (en) 2013-04-04
CL2008000103A1 (es) 2008-07-18
AR064863A1 (es) 2009-04-29

Similar Documents

Publication Publication Date Title
PL2118128T3 (pl) Białka fuzyjne zawierające antygeny odrzucenia nowotworu NY-ESO-1 i LAGE-1
ZA201002160B (en) Human gm-csf antigen binding proteins
HK1219490A1 (zh) 免疫球蛋白融合蛋白
EP2069401A4 (en) MULTISPECIENT EPITOP BINDING PROTEINS AND THEIR USE
IL232008A (en) Protein isolate heterodimer alpha-4-in-cell-7-specific antigen-binding and various aspects thereof
IL200610A0 (en) Human monoclonal anti-ip-10 antibodies and uses thereof
ZA201003759B (en) Antibodies against human nkg2d and uses thereof
IL204839A0 (en) Albumin fusion proteins
HK1138771A1 (en) Antibodies against erbb3 and uses thereof
IL217121A0 (en) Antimicrobial fusion proteins and uses thereof
IL200808A0 (en) Soluble il-17ra/rc fusion proteins and related methods
EP2236604A4 (en) ANTI-NR10 ANTIBODIES AND USE THEREOF
ZA200906516B (en) Novel human anti-R7V antibodies and uses thereof
IL220752A0 (en) Tem8 peptides and vaccines comprising the same
EP2144924A4 (en) FUSION PROTEIN VACCINE
HK1203206A1 (en) Antibody and use thereof
ZA201001260B (en) Immunogenic polypeptides and monoclonal antibodies
HK1171048A1 (zh) 重組人干擾素樣蛋白
EP2484693A4 (en) ANTI-AMYLOID-A3 ANTIBODIES OF HUMAN SERUM AND USE THEREOF
PT2118128E (pt) Proteínas de fusão compreendendo os antigénios de rejeição tumoral ny-eso-1 e lage-1
GB0700759D0 (en) Novel fusion protein
GB0713169D0 (en) Fusion proteins
PL380011A1 (pl) Nowe szkieletowe preparaty białkowe, sposób ich otrzymywania oraz zastosowania
GB0709707D0 (en) Novel fusion protein
HK1082770A1 (en) Supter-antigen fusion proteins and the use thereof